The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: A point of view for an assessment of the risk/benefit profile

Nutrition Journal

Volumn 7, Issue 1, 2008, Pages

  Brambilla, Daria ^a   Mancuso, Cesare ^b   Scuderi, Mariagrazia Rita ^a   Bosco, Paolo ^c   Cantarella, Giuseppina ^a   Lempereur, Laurence ^a   Di Benedetto, Giulia ^a   Pezzino, Salvatore ^a   Bernardini, Renato ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; BILIVERDIN; GLUTATHIONE; HEME OXYGENASE; IRON; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; VITAMIN; ANTIOXIDANT;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ATHEROSCLEROSIS; AUTOIMMUNITY; BRAIN SPONGIOSIS; CANCER INCIDENCE; CELL PROTECTION; DIABETES MELLITUS; HUMAN; IMMUNOPATHOLOGY; ISCHEMIC HEART DISEASE; MULTIPLE SCLEROSIS; NEOPLASM; OXIDATIVE STRESS; PARKINSON DISEASE; REVIEW; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DRUG EFFECT; IMMUNE SYSTEM; METABOLISM; PATHOLOGY; PHYSIOLOGY; RISK ASSESSMENT; TREATMENT OUTCOME;

ANTIOXIDANTS; DIETARY SUPPLEMENTS; HUMANS; IMMUNE SYSTEM; NEOPLASMS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 54949121807     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-7-29     Document Type: Review

References (128)

1. Antioxidants: A tale of two stories. EK Pauwels PA Erba M Kostkiewicz, Drug News Perspect 2007 20 9 579 585 18176663
2. Free radicals and antioxidants in normal physiological functions and human disease. M Valko D Leibfritz J Moncol MT Cronin M Mazur J Telser, Int J Biochem Cell Biol 2007 39 1 44 84 10.1016/j.biocel.2006.07.001 16978905
3. Natural antioxidants in Alzheimer's disease. C Mancuso TE Bates DA Butterfield S Calafato C Cornelius A De Lorenzo AT Dinkova Kostova V Calabrese, Expert Opin Investig Drugs 2007 16 12 1921 1931 10.1517/13543784.16.12.1921 18042001
4. Inflammation as a causative factor in the aetiology of Parkinson's disease. PS Whitton, Br J Pharmacol 2007 150 8 963 976 17339843 10.1038/sj.bjp.0707167
5. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. C Ramassamy, Eur J Pharmacol 2006 545 1 51 64 10.1016/j.ejphar.2006.06.025 16904103
6. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2. DQ Pham R Plakogiannis, Ann Pharmacother 2005 39 12 2065 2072 10.1345/aph.1G271 16288072
7. The use of antioxidants in transmissible spongiform encephalopaties: a case report. JA Drisko, J Am Coll Nutr 2002 21 1 22 25 11838883
8. Free radicals, antioxidants and nutrition. Y Fang S Yang G Wu, Nutrition 2002 18 10 872 10.1016/S0899-9007(02)00916-4 12361782
9. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, N Engl J Med 1994 330 1029 1035 10.1056/ NEJM199404143301501 8127329
10. Free radicals, metals and antioxidants in oxidative stress-induced cancer. M Valko CJ Rhodes J Moncol M Izakovic M Mazur, Chem Biol Interact 2006 160 1 1 40 10.1016/j.cbi.2005.12.009 16430879
11. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. C Mancuso G Scapagnini D Currò AM Giuffrida Stella C De Marco DA Butterfield V Calabrese, Front Biosci 2007 12 1107 1123 10.2741/2130 17127365
12. Bilirubin: an endogenous scavenger of nitric oxide and reactive nitrogen species. C Mancuso G Pani V Calabrese, Redox Rep 2006 11 5 207 213 10.1179/135100006X154978 17132269
13. Albumin-bound bilirubin interacts with nitric oxide by a redox mechanism. C Mancuso A Bonsignore C Capone E Di Stasio G Pani, Antioxid Redox Signal 2006 8 3-4 487 494 10.1089/ars.2006.8.487 16677092
14. Bilirubin and S-nitrosothiols interaction: evidence for a possible role of bilirubin as a scavenger of nitric oxide. C Mancuso A Bonsignore E Di Stasio A Mordente R Motterlini, Biochem Pharmacol 2003 66 12 2355 2363 10.1016/j.bcp.2003.08.022 14637193
15. Markers of oxidative stress in ICU clinical settings: present and future. T Grune MM Berger, Curr Opin Clin Nutr Metab Care 2007 18089952
16. Possible non-classic intracellular and molecular mechanisms of LDL cholesterol action contributing to the development and progression of atherosclerosis. I Gouni-Berthold A Sachinidis, Curr Vasc Pharmacol 2004 2 4 363 370 10.2174/1570161043385466 15320816
17. Redox regulation of cAMP-responsive element-binding protein and induction of manganous superoxide dismutase in nerve growth factor-dependent cell survival. B Bedogni G Pani R Colavitti A Riccio S Borrello M Murphy R Smith ML Eboli T Galeotti, J Biol Chem 2003 278 16510 16519 10.1074/jbc.M301089200 12609977
18. Oxidant signals and oxidative stress. T Finkel, Curr Opin Cell Biol 2003 15 2 247 254 10.1016/S0955-0674(03)00002-4 12648682
19. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. R Colavitti G Pani B Bedogni R Anzevino S Borrello J Waltenberger T Galeotti, J Biol Chem 2002 277 3101 3108 10.1074/jbc.M107711200 11719508
20. A redox signaling mechanism for density-dependent inhibition of cell growth. G Pani R Colavitti B Bedogni R Anzevino S Borrello T Galeotti, J Biol Chem 2000 275 38891 38899 10.1074/jbc.M007319200 10988296
21. Endogenous oxygen radicals modulate protein tyrosine phosphorylation and JNK-1 activation in lectin-stimulated thymocytes. G Pani R Colavitti S Borrello T Galeotti, Biochem J 2000 347 173 181 10727416 10.1042/0264-6021:3470173
22. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. K Schulze-Osthoff R Beyaert V Vandevoorde G Haegeman W Fiers, EMBO J 1993 12 3095 3104 8344250
23. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. T Jabs, Biochem Pharmacol 1999 57 231 245 10.1016/S0006-2952(98)00227-5 9890550
24. Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling. BJ Hawkins M Madesh CJ Kirkpatrick AB Fisher, Mol Biol Cell 2007 18 6 2002 2012 17360969 10.1091/mbc.E06-09-0830
25. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. C Bubici S Papa K Dean G Franzoso, Oncogene 2006 25 51 6731 6748 10.1038/sj.onc.1209936 17072325
26. Reactive species-mediated regulation of cell signaling and the cell cycle: the role of MAPK. Y Cakir SW Ballinger, Antioxid Redox Signal 2005 7 5-6 726 740 10.1089/ars.2005.7.726 15890019
27. Hydrogen peroxide induces up-regulation of Fas in human endothelial cells. T Suhara K Fukuo T Sugimoto S Morimoto T Nakahashi S Hata M Shimizu T Ogihara, J Immunol 1998 160 4042 4047 9558114
28. Vitamin E inhibits CD95 ligand expression and protects T cell from activation-induced cell death. ML Weber MA Weigand M Giaisi D Suss MK Treiber S Baumann E Ritsou R Breitkretz PH Krammer, J Clin Invest 2002 110 681 690 12208869
29. Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. JH Haendeler AM Zeiher S Dimmeler, Eur J Pharmacol 1996 317 407 411 10.1016/S0014-2999(96)00759-5 8997628
30. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. L Fialkow Y Wang GP Downey, Free Radic Biol Med 2007 42 2 153 164 10.1016/j.freeradbiomed.2006.09.030 17189821
31. The function of the NADPH oxidase of phagocytes, and its relationship to other NOXs. P Behe AW Segal, Biochem Soc Trans 2007 35 Pt 5 1100 1103 17956288
32. Myeloperoxidase: a target for new drug development? E Malle PG Furtmüller W Sattler C Obinger, Br J Pharmacol 2007 152 6 838 854 10.1038/sj.bjp.0707358 17592500
33. Selective plasmenylcholine oxidation by hypochlorous acid: formation of lysophosphatidylcholine chlorohydrins. MC Messner CJ Albert FF Hsu DA Ford, Chem Phys Lipids 2006 144 1 34 44 10.1016/j.chemphyslip.2006.06.003 16859663
34. Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical. Z Shen W Wu SL Hazen, Biochemistry 2000 39 18 5474 5482 10.1021/bi992809y 10820020
35. Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. CC Winterbourn JJ van den Berg E Roitman FA Kuypers, Arch Biochem Biophys 1992 296 2 547 555 10.1016/0003-9861(92)90609-Z 1321589
36. Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. WG Rice SJ Weiss, Science 1990 249 4965 178 181 10.1126/science.2371565 2371565
37. Tissue destruction by neutrophils. SJ Weiss, N Engl J Med 1989 320 365 2536474
38. Vitamin E and immune functions. A Bendich, Basic Life Sci 1988 49 615 620 3074789
39. Oxidative stress induces age-dependent changes in lymphocyte protein synthesis and second messenger levels. J Lopez-Hellin E Garcia-Arumi S Schwartz, Life Sci 1998 63 1 13 21 10.1016/S0024-3205(98)00231-8 9667760
40. Contribution of selected vitamins and trace elements to immune function. ES Wintergerst S Maggini DH Hornig, Ann Nutr Metab 2007 51 4 301 23 10.1159/000107673 17726308
41. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomised controlled trial. SN Meydani M Meydani JB Blumberg LS Leka G Siber R Loszewski C Thompson MC Pedrosa RD Diamond BD Stollar, JAMA 1997 277 17 1380 1386 10.1001/jama.277.17.1380 9134944
42. The immune system in the oxidative stress conditions of aging and hypertension: favorable effects of antioxidants and physical exercise. M De la Fuente A Hernanz MC Vallejo, Antioxid Redox Signal 2005 7 9-10 1356 1366 10.1089/ars.2005.7.1356 16115041
43. Effects of antioxidants on immune system ageing. M De la Fuente, Eur J Clin Nutr 2002 56 Suppl 3 5 8 10.1038/sj.ejcn.1601476
44. Physiopathology of natural auto-antibodies: the case for regulation. S Zelenay MF Moraes Fontes C Fesel J Demengeot A Coutinho, J Autoimmun 2007 29 4 229 235 10.1016/j.jaut.2007.07.011 17967665
45. Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis in Wiskott-Aldrich syndrome. S Pasic D Micic M Kuzmanovic, Acta Paediatr 2003 92 7 859 861 10.1080/08035250310003631 12892170
46. The role of metals in autoimmunity and the link to neuroendocrinology. J Stejskal VD Stejskal, Neuro Endocrinol Lett 1999 20 6 351 364 11458198
47. Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicities. JP Bressler L Olivi JH Cheong Y Kim A Maerten D Bannon, Hum Exp Toxicol 2007 26 3 221 229 10.1177/0960327107070573 17439925
48. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. RA Yokel, J Alzheimers Dis 2006 10 2-3 223 253 17119290
49. Oxidative stress and iron homeostasis: mechanistic and health aspects. D Galaris K Pantopoulos, Crit Rev Clin Lab Sci 2008 45 1 1 23 10.1080/ 10408360701713104 18293179
50. Metals and neurotoxicology. RO Wright A Baccarelli, J Nutr 2007 137 12 2809 2813 18029504
51. Copper and Alzheimer's disease. PS Donnelly Z Xiao AG Wedd, Curr Opin Chem Biol 2007 11 2 128 133 10.1016/j.cbpa.2007.01.678 17300982
52. Modulation of cholinergic systems by manganese. Y Finkelstein D Milatovic M Aschner, Neurotoxicology 2007 28 5 1003 1014 10.1016/j.neuro.2007.08.006 17920128
53. Metals, toxicity and oxidative stress. M Valko H Morris MT Cronin, Curr Med Chem 2005 12 10 1161 1208 10.2174/0929867053764635 15892631
54. Organic mercury compounds and autoimmunity. S Havarinasab P Hultman, Autoimmun Rev 2005 4 5 270 275 10.1016/j.autrev.2004.12.001 15990073
55. Mechanisms of stimulation of the immune response by aluminum adjuvants. H HogenEsch, Vaccine 2002 20 Suppl 3 34 39 10.1016/S0264-410X(02)00169-X
56. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. L Casciola-Rosen F Wigley A Rosen, J Exp Med 1997 185 1 71 79 8996243 10.1084/jem.185.1.71
57. Role of metal-catalyzed oxidation reactions in the early pathogenesis of scleroderma. A Rosen L Casciola-Rosen F Wigley, Curr Opin Rheumatol 1997 9 6 538 543 10.1097/00002281-199711000-00010 9375283
58. Antioxidants inhibit mercuric chloride-induced early vasculitis. Z Wu DR Turner DB Oliveira, Int Immunol 2002 14 3 267 273 10.1093/intimm/14.3.267 11867563
59. AVEMAR (a new benzoquinone-containing natural product) administration interferes with the Th2 response in experimental SLE and promotes amelioration of the disease. M Ehrenfeld M Blank Y Shoenfeld M Hidvegi, Lupus 2001 10 9 622 627 10.1191/096120301682430203 11678450
60. Fermented wheat germ extract inhibits glycolysis/pentose cycle enzymes and induces apoptosis through poly(ADP-ribose) polymerase activation in Jurkat T-cell leukemia tumor cells. B Comin-Anduix LG Boros S Marin J Boren C Callol-Massot JJ Centelles JL Torres N Agell S Bassilian M Cascante, J Biol Chem 2002 277 48 46408 46414 10.1074/jbc.M206150200 12351627
61. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals. M Hidvégi E Ráso R Tömöskö zi-Farkas S Paku K Lapis B Szende, Anticancer Res 1998 18 4A 2353 2358 9703878
62. Recovery mechanism of the antioxidant activity from carnosic acid quinone, an oxidized sage and rosemary antioxidant. T Masuda Y Inaba T Maekawa Y Takeda H Tamura H Yamaguchi, J Agric Food Chem 2002 50 21 5863 5869 10.1021/jf025605o 12358451
63. Developments in the synovial biology field 2006. A Knedla E Neumann U Müller-Ladner, Arthritis Res Ther 2007 9 2 209 17442097 10.1186/ar2140
64. TRPV1 mediates cell death in rat synovial fibroblasts through calcium entry-dependent ROS production and mitochondrial depolarization. F Hu WW Sun XT Zhao ZJ Cui WX Yang, Biochem Biophys Res Commun 2008 16;369 4 989 93 10.1016/j.bbrc.2008.02.155
65. Intracellular oxidative activation in synovial fluid neutrophils from patients with rheumatoid arthritis but not from other arthritis patients. J Cedergren T Forslund T Sundqvist T Skogh, J Rheumatol 2007 34 11 2162 2170 17937476
66. Antioxidant intervention in rheumatoid arthritis: results of an open pilot study. RM van Vugt PJ Rijken AG Rietveld AC van Vugt BA Dijkmans, Clin Rheumatol 2008 27 6 771 775 18274814 10.1007/s10067-008-0848-6
67. Antioxidants as adjuvant therapy in rheumatoid disease. A preliminary study. M Helmy M Shohayeb MH Helmy EA el-Bassiouni, Arzneimittelforschung 2001 51 4 293 298 11367869
68. Role of inherited defects decreasing Fas function in autoimmunity. U Dianzani A Chiocchetti U Ramenghi, Life Sci 2003 72 25 2803 2824 10.1016/S0024-3205(03)00196-6 12697265
69. Oxidative stress and cellular stress response in diabetic nephropathy. V Calabrese C Mancuso M Sapienza E Puleo S Calafato C Cornelius M Finocchiaro A Mangiameli M Di Mauro AM Stella P Castellino, Cell Stress Chaperones 2007 12 4 299 306 18229449 10.1379/CSC-270.1
70. Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease. V Calabrese R Sultana G Scapagnini E Guagliano M Sapienza R Bella J Kanski G Pennisi C Mancuso AM Stella DA Butterfield, Antioxid Redox Signal 2006 8 11-12 1975 1986 17034343
71. Heme oxygenase and cyclooxygenase in the central nervous system: a functional interplay. C Mancuso M Perluigi C Cini C De Marco AM Giuffrida Stella V Calabrese, J Neurosci Res 2006 84 7 1385 1391 10.1002/jnr.21049 16998916
72. Heme oxygenase and its products in the nervous system. C Mancuso, Antioxid Redox Signal 6 5 878 887 15345148
73. Regulatory T cell maintenance of dominant tolerance: induction of tissue self-defense? V Oliveira A Agua-Doce J Duarte MP Soares L Graca, Transpl Immunol 2006 17 1 7 10 10.1016/j.trim.2006.09.028 17157205
74. An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells. TM Brusko CH Wasserfall A Agarwal MH Kapturczak MA Atkinson, J Immunol 2005 174 9 5181 5186 15843512
75. Curcumin activates defensive genes and protects neurons against oxidative stress. G Scapagnini C Colombrita M Amadio V D'Agata E Arcelli M Sapienza A Quattrone V Calabrese, Antioxid Redox Signal 2006 8 3-4 395 403 10.1089/ars.2006.8.395 16677086
76. Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. G Scapagnini R Foresti V Calabrese AM Giuffrida Stella CJ Green R Motterlini, Mol Pharmacol 2002 61 3 554 561 10.1124/mol.61.3.554 11854435
77. Micronutrients prevent cancer and delay aging. BN Ames, Toxicol Letters 1998 102 103 105 10.1016/S0378-4274(98)00269-0
78. Potential synergy of phytochemicals in cancer prevention: mechanism of action. RH Liu, J Nutr 2004 134 Suppl 12 3479S 3485S
79. Olives and olive oil in cancer prevention. RW Owen R Haubner G Wurtele E Hull B Spiegelhalder H Bartsch, Eur J Cancer Prev 2004 13 4 319 326 10.1097/01.cej.0000130221.19480.7e 15554560
80. Can antioxidant vitamins materially reduce oxidative damage in humans? MR McCall B Frei, Free Rad Biol Med 1999 26 1034 1053 10.1016/S0891-5849(98)00302- 5 10232849
81. Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes. E Villamor WW Fawzi, Clin Microbiol Rev 2005 18 3 446 464 16020684 10.1128/CMR.18.3.446-464.2005
82. Carotenoid action on the immune response. BP Chew JS Park, J Nutr 2004 134 1 257S 261S 14704330
83. Vitamin A, infection, and immune function. CB Stephensen, Annu Rev Nutr 2001 21 167 192 10.1146/annurev.nutr.21.1.167 11375434
84. The effect of vitamin E supplementation on antioxidant enzyme activities and lipid peroxidation levels in hemodialysis patients. B Giray E Kan M Bali F Hincal N Basaran, Clin Chim Acta 2003 338 1-2 91 98 10.1016/j.cccn.2003.07.020 14637272
85. Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET). ML Neuhouser RE Patterson MD Thornquist GS Omenn IB King GE Goodman, Cancer Epidemiol Biomarkers Prev 2003 12 4 350 358 12692110
86. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. WJ Blot JY Li PR Taylor W Guo S Dawsey GQ Wang CS Yang SF Zheng M Gail GY Li, J Natl Cancer Inst 1993 85 18 1483 1492 10.1093/jnci/85.18.1483 8360931
87. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future. GS Omenn, Eur J Cancer Prev 2007 16 3 184 191 10.1097/01.cej.0000215612.98132.18 17415088
88. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. GS Omenn GE Goodman MD Thornquist J Balmes MR Cullen A Glass JP Keogh FL Meyskens Jr B Valanis JH Williams Jr S Barnhart MG Cherniack CA Brodkin S Hammar, J Natl Cancer Inst 1996 88 21 1550 1559 10.1093/jnci/88.21.1550 8901853
89. Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis. A Bardia IM Tleyjeh JR Cerhan AK Sood PJ Limburg PJ Erwin VM Montori, Mayo Clin Proc 2008 83 1 23 34 18173999
90. Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. CG Slatore AJ Littman DH Au JA Satia E White, Am J Respir Crit Care Med 177 5 524 30 2008 Mar 1 10.1164/rccm.200709-1398OC 17989343
91. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. G Bjelakovic D Nikolova LL Gluud RG Simonetti C Gluud, JAMA 297 8 842 57 2007 Feb 28 10.1001/jama.297.8.842 17327526
92. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. Anonymous, N Engl J Med 1994 330 15 1029 1035 10.1056/NEJM199404143301501 8127329
93. Mitogenic and apoptotic signaling by carotenoids: involvement of a redox mechanism. P Palozza S Serini F Di Nicuolo G Calviello, IUBMB Life 2001 52 1-2 77 81 10.1080/15216540252774810 11795599
94. beta-Carotene exacerbates DNA oxidative damage and modifies p53-related pathways of cell proliferation and apoptosis in cultured cells exposed to tobacco smoke condensate. P Palozza S Serini F Di Nicuolo A Boninsegna A Torsello N Maggiano FO Ranelletti FI Wolf G Calviello A Cittadini, Carcinogenesis 2004 25 8 1315 1325 10.1093/carcin/bgh142 15073048
95. Reactions of beta-carotene with cigarette smoke oxidants. Identification of carotenoid oxidation products and evaluation of the prooxidant/antioxidant effect. DL Baker ES Krol N Jacobsen DC Liebler, Chem Res Toxicol 1999 12 6 535 543 10.1021/tx980263v 10368317
96. beta-Carotene and cigarette smoke condensate regulate heme oxygenase-1 and its repressor factor Bach1: relationship with cell growth. P Palozza S Serini D Currò G Calviello K Igarashi C Mancuso, Antioxid Redox Signal 2006 8 5-6 1069 1080 10.1089/ars.2006.8.1069 16771696
97. Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts. L Li P Grenard JT Nhieu B Julien A Mallat A Habib S Lotersztajn, Gastroenterology 2003 125 2 460 469 10.1016/S0016-5085(03)00906-5 12891549
98. Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. KJ Peyton SV Reyna GB Chapman D Ensenat XM Liu H Wang AI Schafer W Durante, Blood 2002 99 12 4443 4448 10.1182/blood.V99. 12.4443 12036874
99. Carbon monoxide inhibits human airway smooth muscle cell proliferation via mitogen-activated protein kinase pathway. R Song RS Mahidhara F Liu W Ning LE Otterbein AM Choi, Am J Respir Cell Mol Biol 2002 27 5 603 610 12397020
100. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. R Ollinger M Bilban A Erat A Froio J McDaid S Tyagi E Csizmadia AV Graça-Souza A Liloia MP Soares LE Otterbein A Usheva K Yamashita FH Bach, Circulation 2005 112 7 1030 1039 10.1161/CIRCULATIONAHA.104.528802 16087796
101. Vitamin E supplementation enhances immune response in the elderly. Anonymous, Nutr Rev 1992 50 3 85 87 1565294
102. Oxidative stress and neurotoxicity. LM Sayre G Perry MA Smith, Chem Res Toxicol 2008 21 1 172 188 10.1021/tx700210j 18052107
103. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. V Calabrese C Mancuso M Calvani E Rizzarelli DA Butterfield AM Stella, Nat Rev Neurosci 2007 8 10 766 775 10.1038/nrn2214 17882254
104. In vivo induction of heat shock proteins in the substantia nigra following L-DOPA administration is associated with increased activity of mitochondrial complex I and nitrosative stress in rats: regulation by glutathione redox state. V Calabrese C Mancuso A Ravagna M Perluigi C Cini C De Marco DA Butterfield AM Stella, J Neurochem 2007 101 3 709 717 10.1111/j.1471-4159.2006.04367.x 17241115
105. Immune tolerance and control of CNS autoimmunity: from animal models to MS patients. C Cassan RS Liblau, J Neurochem 2007 100 4 883 892 10.1111/j.1471-4159.2006.04270.x 17181557
106. Multiple sclerosis: a complicated picture of autoimmunity. HF McFarland R Martin, Nat Immunol 2007 8 9 913 919 10.1038/ni1507 17712344
107. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. A Castegna M Aksenov M Aksenova V Thongboonkerd JB Klein WM Pierce R Booze WR Markesbery DA Butterfield, Free Radic Biol Med 2002 33 4 562 571 10.1016/S0891-5849(02)00914-0 12160938
108. Proteomic identification of nitrated proteins in Alzheimer's disease brain. A Castegna V Thongboonkerd JB Klein B Lynn WR Markesbery DA Butterfield, J Neurochem 2003 85 6 1394 1401 10.1046/j.1471-4159.2003.01786.x 12787059
109. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. DA Butterfield T Reed M Perluigi C De Marco R Coccia C Cini R Sultana, Neurosci Lett 2006 397 3 170 173 10.1016/j.neulet.2005.12.017 16413966
110. Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis. OA Bizzozero G DeJesus K Callahan A Pastuszyn, J Neurosci Res 2005 81 5 687 695 10.1002/jnr.20587 16007681
111. Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. E Floor MG Wetzel, J Neurochem 1998 70 1 268 275 9422371
112. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. A Yoritaka N Hattori K Uchida M Tanaka ER Stadtman Y Mizuno, Proc Natl Acad Sci USA 1996 93 7 2696 2701 8610103 10.1073/pnas.93.7.2696
113. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. J Zhang G Perry MA Smith D Robertson SJ Olson DG Graham TJ Montine, Am J Pathol 1999 154 5 1423 1429 10329595
114. Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes. V Calabrese E Guagliano M Sapienza M Panebianco S Calafato E Puleo G Pennisi C Mancuso DA Butterfield AG Stella, Neurochem Res 2007 32 4-5 757 773 10.1007/s11064-006-9203-y 17191135
115. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors. DM Araujo PA Lapchak, Neuroscience 1994 61 4 745 754 10.1016/0306-4522(94)90398-0 7838374
116. Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections). GE Ringheim K Conant, J Neuroimmunol 2004 147 1-2 43 49 10.1016/j.jneuroim.2003.10.013 14741426
117. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. PL McGeer M Schulzer EG McGeer, Neurology 1996 47 2 425 432 8757015
118. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease. V Calabrese DA Butterfield AM Stella, Ital J Biochem 2003 52 4 177 181 15141484
119. Nutritional approaches to combat oxidative stress in Alzheimer's disease. D Butterfield A Castegna C Pocernich J Drake G Scapagnini V Calabrese, J Nutr Biochem 2002 13 8 444 10.1016/S0955-2863(02)00205-X 12165357
120. Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study. SA Reines GA Block JC Morris G Liu ML Nessly CR Lines BA Norman CC Baranak Rofecoxib Protocol 091 Study Group, Neurology 2004 62 1 66 71 10.1159/000080761 14718699
121. Alzheimer's Disease Cooperative Study. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. PS Aisen KA Schafer M Grundman E Pfeiffer M Sano KL Davis MR Farlow S Jin RG Thomas LJ Thal, JAMA 2003 289 21 2819 2826 10.1001/jama.289.21.2819 12783912
122. Cognitive change in motor neurone disease/amyotrophic lateral sclerosis (MND/ALS). D Neary JS Snowden DM Mann, J Neurol Sci 2000 180 1-2 15 20 10.1016/S0022-510X(00)00425-1 11090859
123. Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis. JA Kiernan AJ Hudson, Brain 1991 114 Pt 2 843 853 10.1093/brain/114.2.843 2043953
124. Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS. BR Roberts JA Tainer ED Getzoff DA Malencik SR Anderson VC Bomben KR Meyers PA Karplus JS Beckman, J Mol Biol 2007 373 4 877 890 10.1016/j.jmb.2007.07.043 17888947
125. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Kong Z Xu, J Neurosci 1998 18 9 3241 3250 9547233
126. A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group. C Desnuelle M Dib C Garrel A Favier, Amyotroph Lateral Scler Other Motor Neuron Disord 2001 2 1 9 18 10.1080/146608201300079364 11465936
127. Lost in translation: treatment trials in the SOD1 mouse and in human ALS. M Benatar, Neurobiol Dis 2007 26 1 1 13 10.1016/j.nbd.2006.12.015 17300945
128. AEOL-10150 (Aeolus). RW Orrell, Curr Opin Investig Drugs 2006 7 1 70 80 16425674